Patient Leaflet Updated 27-Jul-2021 | Atnahs Pharma UK Ltd
Kytril 1 mg & 2 mg film-coated tablets
Kytril 1 mg film-coated tablets
Kytril 2 mg film-coated tablets
Granisetron
1. What Kytril is and what it is used for
2. What you need to know before you take Kytril
3. How to take Kytril
4. Possible side effects
5. How to store Kytril
6. Contents of the pack and information
Kytril contains the active substance granisetron. This belongs to a group of medicines called ‘5-HT3 receptor antagonists’ or ‘anti-emetics’. These tablets are only for use in adults.
Kytril is used to prevent or treat nausea and vomiting (feeling and being sick) caused by other medical treatments, such as chemotherapy or radiotherapy for cancer.
If you are not sure, talk to your doctor, nurse or pharmacist before taking these tablets.
Talk to your doctor, nurse or pharmacist before using these tablets, especially if you:
Serotonin Syndrome is a rare but potentially life-threatening reaction that can occur with Kytril. It can cause serious changes in how your brain, muscles, and digestive system work. The reaction can occur if you take Kytril alone but is more likely to occur if you take Kytril with certain other medications. Be sure to tell your doctor, nurse or pharmacist all the medicines you are taking.
Children should not take these tablets.
Please tell your doctor, nurse or pharmacist if you are taking or have recently taken or might take any other medicines, including medicines obtained without a prescription. This is because Kytril can affect the way some medicines work. Also some other medicines can affect the way these tablets work.
In particular, tell your doctor, nurse or pharmacist if you are taking the following medicines:
You should not take these tablets if you are pregnant, trying to get pregnant or are breast-feeding, unless your doctor has told you to.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor, nurse or pharmacist for advice before taking this medicine.
Kytril has no or negligible effect on your ability to drive or use any tools or machines.
Kytril contains lactose (a type of sugar). If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Kytril is essentially ‘sodium free’ as it contains less than 1 mmol sodium (23 mg) per dose (2 mg).
Always take this medicine exactly as your doctor has told you. Check with your doctor, nurse or pharmacist if you are not sure.
The recommended dose of Kytril varies from one patient to another. It depends on your age, weight, and whether you are being given the medicine to prevent, or treat, nausea and vomiting. The doctor will work out how much to give you.
Your first dose of Kytril will usually be given an hour before your radio- or chemotherapy. The dose will be taken either as:
for up to a week after your radio- or chemotherapy.
The dose will usually be taken either as:
If you think you have taken too many of the tablets talk to your doctor or nurse. The symptoms of overdose include mild headaches. You will be treated depending on your symptoms.
If you think you have forgotten to take your medicine speak to your doctor or nurse.
Do not take a double dose to make up for a forgotten tablet.
Do not stop taking your medicine before the treatment is finished. If you do stop taking your medicine, your symptoms may return.
If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. If you notice the following problem you must see a doctor straight away:
Other side effects that may be experienced while taking this medicine are:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. These measures will help to protect the environment.
The active substance is granisetron.
Each 1 mg film-coated tablet contains 1 mg granisetron (as the hydrochloride).
Each 2 mg film-coated tablet contains 2 mg granisetron (as the hydrochloride).
The other ingredients are:
Lactose monohydrate
Hypromellose
Sodium starch glycolate
Cellulose, microcrystalline
Magnesium stearate
Film-coat:
Hypromellose
Titanium dioxide (E171)
Macrogol 400
Polysorbate 80
The tablets are white to almost white triangular biconvex tablets imprinted with K1 on one side.
The tablets are white to almost white triangular biconvex tablets imprinted with K2 on one side.
Opaque PVC blisters sealed with an aluminium foil containing 2 or 10 tablets (1 mg) or 1, 5 or 10 tablets (2 mg). Not all pack sizes may be marketed.
Marketing Authorisation Holder
Manufacturer
Or
This medicinal product is authorised in the Member States of the EEA under the following names:
Austria, Belgium, Czech Republic, Estonia, Finland, France, Ireland, Italy, Netherlands, Slovenia, Spain and United Kingdom: Kytril
Germany: Kevatril
This leaflet was last revised in October 2017
Other sources of information.
uk-pil-Kytril-tracked-161214-1mg-2mg-tabs
Sovereign House, Miles Gray Road, Basildon, SS14 3FR
(+44) 01268 943 700
www.pharmanovia.com
(+44) 01268 943 700
(+44) 01268 943 700